Stanford researchers in the CHARM Lab have developed a compact pneumatic control system for precise pressure modulation in for wearable, multi-device haptic systems and smart textiles.
Stanford scientists have discovered a novel approach to address cardiovascular complications resulting from cancer chemotherapy, particularly those caused by tyrosine kinase inhibitors (TKIs).
Stanford researchers have developed a human spleen organoid platform that models inflammation and autoimmune responses to bacterial peptidoglycans in a physiologically relevant human immune setting.
Stanford researchers have designed a electrochemical sensor system for continuous analyte measurement and tracking in complex biological samples (i.e. blood and serum) with a wide range of clinical and non clinical applications.
Stanford researchers have developed novel AsCas12a-expressing mouse models for simultaneous editing of multiple genomic loci in vivo with unique targeting capabilities relative to traditional Cas9 models, enabling the rapid creation of complex genotypes in somatic cells and ca
Researchers from Stanford developed recombinant polypeptide-cytokine conjugates and methods to induce antigen-specific regulatory T cells (Treg) for the treatment of inflammatory and autoimmune diseases.
Researchers at Stanford have developed compounds for inhibiting the epidermal growth factor receptor (EGFR) that covalently label a nucleophile that has not been targeted before.
Stanford researchers have developed a high-throughput platform to engineer synthetic ETS transcription factors that enhance human T cell function beyond natural TFs, enabling precise and scalable cellular reprogramming for immunotherapy and other therapies.
Stanford researchers have developed a high-throughput platform that designs, delivers, and screens synthetic microRNAs to precisely reprogram human T cells and improve the efficacy of CAR T cell therapies.
Researchers at Stanford have developed a novel method of using macrocyclic compounds that act as inhibitors of epidermal growth factor receptor (EGFR) for the treatment or prevention of kinase-mediated disorders, including cancer and other proliferation diseases.
Stanford scientists have developed a generative learning framework paired with a compact wearable EMG device that extrapolates limited sensor inputs to reconstruct muscle activity equivalent to that captured by high-density sensor arrays.
Stanford researchers have created a next-generation platform for producing real meat without raising or slaughtering animals, using a combination of rejuvenated muscle cells and a fully edible, protein-rich scaffold.
Stanford researchers have developed a novel PET agent for diseases stemming from T cell origin. The probes help visualize the disease status as well as the progress of therapy.